The effect of azithromycin treatment on respiratory morbidity in children with down syndrome

Abstract Background Children with Down syndrome (DS) often experience recurrent and prolonged hospitalizations from respiratory infections. While Azithromycin has been increasingly used for lower-respiratory tract infections (LRTIs) in children, its potential benefits for DS patients are unexplored....

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Inbal Golan-Tripto, Omer Dor, Noga Arwas, Itai Hazan, Guy Hazan, Aviv Goldbart
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2025-01-01
Saila:	BMC Pediatrics
Gaiak:	Down syndrome Azithromycin Respiratory infections Children Respiratory morbidity
Sarrera elektronikoa:	https://doi.org/10.1186/s12887-025-05421-1
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!